| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/08/2007 | CN101011348A Anti-cancer composition loading both mtrosourea medicament and alkaloids medicament |
| 08/08/2007 | CN101011347A Slow release injection containing platinum compound and topoisomerase inhibitor |
| 08/08/2007 | CN101011346A Anti-cancer composition loading both mtrosourea medicament and synergist |
| 08/08/2007 | CN101011345A Slow release injection containing platinum compound and alkylating agent |
| 08/08/2007 | CN101011344A Anti-cancer composition loading both mtrosourea medicament and alkylating agent |
| 08/08/2007 | CN101011343A Slow release injection containing anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011342A Slow release injection containing anti-metabolism medicament and platinum compound |
| 08/08/2007 | CN101011341A Slow release injection containing anti-metabolism medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011340A Anti-cancer composition loading both anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011316A Process for preparing micronized medicine by using micro-reactor |
| 08/08/2007 | CN101011184A Tobacco substitution chrysanthemum health cigarette |
| 08/08/2007 | CN101011150A Sugar-free seabuckthorn lozenge and its preparing process |
| 08/08/2007 | CN101011146A Health food capable of decreasing blood sugar |
| 08/08/2007 | CN101011058A Disinfectant and/or bactericidal aqueous compositions |
| 08/07/2007 | US7253262 Dried blood factor composition comprising trehalose |
| 08/07/2007 | US7253209 Dissolving in iodinated poppyseed oil fatty ester |
| 08/07/2007 | US7252952 In vivo production of cyclic peptides for inhibiting protein—protein interaction |
| 08/07/2007 | US7252842 Encapsulation of hydrophilic active agents in biodegradable polymers; employs a minimal volume of surfactant solution resulting in a reduced production time |
| 08/07/2007 | US7252841 Dry reactants that include calcium and phosphate sources, as well as a monovalent cation dihydrogen phosphate salt, are combined with a setting fluid and the combined reactants are mixed to produce the settable formulation |
| 08/07/2007 | US7252840 Administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent, or any combination thereof, and a hydrophobic amino acid or salt thereof |
| 08/07/2007 | US7252839 Comprising a body construction and at least one capsule containing a pharmaceutical formulation, capsule having at least a first end and a second end |
| 08/07/2007 | US7252838 Ligating band also may include an inner diffusion barrier disposed between the elastomeric layer and the inner drug releasing layer |
| 08/07/2007 | US7252830 Moisturizing compositions |
| 08/07/2007 | US7252649 Implantable vascular access device |
| 08/07/2007 | CA2434655C Cubic liquid crystalline phase precursor |
| 08/07/2007 | CA2361392C Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 08/07/2007 | CA2351536C Therapeutic anti-fungal nail preparation |
| 08/07/2007 | CA2326840C Carvedilol-galenics |
| 08/07/2007 | CA2325842C Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 08/07/2007 | CA2324887C Ophthalmic composition comprising a .beta.-blocker |
| 08/07/2007 | CA2316981C Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 08/07/2007 | CA2289196C Sustained-release delayed gels |
| 08/07/2007 | CA2289088C Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 08/07/2007 | CA2281946C Pharmaceutical formulations containing poorly soluble drug substances |
| 08/07/2007 | CA2259466C Dental floss with increased loading weight |
| 08/07/2007 | CA2257904C Method for preparing an injectable preparation and device for implementing same |
| 08/07/2007 | CA2246568C Phosphatidyl oligoglycerols |
| 08/07/2007 | CA2244679C Tranilast-containing preparation for external application and method of producing the same |
| 08/07/2007 | CA2234282C Drug-resin complexes stabilized by chelating agents |
| 08/07/2007 | CA2184842C New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 08/07/2007 | CA2124801C Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 08/02/2007 | WO2007087418A2 Composition and method for neuromuscular blockade |
| 08/02/2007 | WO2007087416A2 Methods of increasing oral bioavailability of tetracyclines |
| 08/02/2007 | WO2007087256A2 Method of preparing dendritic drugs |
| 08/02/2007 | WO2007086929A1 Nanoparticle formation of pharmaceutical ingredients |
| 08/02/2007 | WO2007086923A2 Controlled and sustained gene transfer mediated by thiol-modified polymers |
| 08/02/2007 | WO2007086914A2 Nanoparticulate clopidogrel formulations |
| 08/02/2007 | WO2007086891A1 Levetiracetam formulations and methods for their manufacture |
| 08/02/2007 | WO2007086846A1 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 08/02/2007 | WO2007086836A1 Foaming granule and method for making same |
| 08/02/2007 | WO2007086694A1 Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 08/02/2007 | WO2007086692A1 Multiple unit type sustained release oral formulation and process for the preparation thereof |
| 08/02/2007 | WO2007086689A1 A solid dispersion comprising ubidecarenone, a process for preparing the same and a pharmaceutical composition comprising the same |
| 08/02/2007 | WO2007086613A1 Enzymatically crosslinked protein nanoparticles |
| 08/02/2007 | WO2007086586A1 Low-moisture-content hard capsule and production method therefor |
| 08/02/2007 | WO2007086582A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME |
| 08/02/2007 | WO2007086541A2 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 08/02/2007 | WO2007086536A2 Soft-gelatin capsule formulation |
| 08/02/2007 | WO2007086493A1 Medicine for transnasal administration |
| 08/02/2007 | WO2007086457A1 Quickly disintegrating tablet produced by direct dry-tabletting |
| 08/02/2007 | WO2007086078A2 Novel pharmaceutical compositions and process of preparation thereof |
| 08/02/2007 | WO2007086039A1 A method of producing porous microparticles |
| 08/02/2007 | WO2007085990A1 Method for producing a particle comprising a gas core and a shell and particles thus obtained |
| 08/02/2007 | WO2007085888A1 Controlled release formulations of methylcobalamin |
| 08/02/2007 | WO2007085840A1 Emulsion |
| 08/02/2007 | WO2007085835A1 Chewable capsules |
| 08/02/2007 | WO2007085637A1 Tamper resistant dosage forms |
| 08/02/2007 | WO2007085615A1 Process for loading polymer particles with drug |
| 08/02/2007 | WO2007085498A1 Pharmaceutical forms in film form for use in the mouth (wafers) |
| 08/02/2007 | WO2007068311A9 Oral delivery of protein drug using microemulsion |
| 08/02/2007 | WO2007065716A3 Preparation of powders containing colloidal particles |
| 08/02/2007 | WO2007064658A9 Safe and effective methods of administering therapeutic agents |
| 08/02/2007 | WO2007060384A3 Respirable powders |
| 08/02/2007 | WO2007059953A8 Formulation comprising a polyphenol-containing composition and isomaltulose |
| 08/02/2007 | WO2007059950A3 Dry powder pharmaceutical formulations of purine a2a agonists |
| 08/02/2007 | WO2007057201A3 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 08/02/2007 | WO2007057178A3 Angiogenesis-promoting substrate |
| 08/02/2007 | WO2007048220A3 Trazodone composition for once a day adminisitiation |
| 08/02/2007 | WO2007042468A3 Aerosol formulation for the inhalation of beta agonists |
| 08/02/2007 | WO2007041482A3 Topical anesthetic for dental procedures |
| 08/02/2007 | WO2007036745A3 Interleukin-13 antibody composition |
| 08/02/2007 | WO2007032962A3 Compositions and methods for intranasal delivery of tricyclic cannabinoids |
| 08/02/2007 | WO2007027720A3 Dried milled granulate and methods |
| 08/02/2007 | WO2007027494A3 Morphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino [4, 5-b] indole-1-acetamide |
| 08/02/2007 | WO2007026180A3 Improvements in the stabilisation of biological materials |
| 08/02/2007 | WO2007017423A3 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 08/02/2007 | WO2007016093A3 Peroxide removal from drug delivery vehicle |
| 08/02/2007 | WO2007009989A3 COMPOSITION CONTAINING A SIO2-NANOPARTICLE LIPOSOMAL DISPERSION AND AN ß-1,3-LINKED GLUCAN-ETHER DERIVATIVE |
| 08/02/2007 | WO2006125620A3 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| 08/02/2007 | WO2006052767A3 Compositions and methods for stabilizing liposomal camptothecin formulations |
| 08/02/2007 | WO2006048017A8 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 08/02/2007 | WO2005011595A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
| 08/02/2007 | US20070179327 Process for producing 1-octene from butadiene in the presence of titanium catalysts |
| 08/02/2007 | US20070179176 Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy |
| 08/02/2007 | US20070179117 Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery |
| 08/02/2007 | US20070179099 Methods of cholesterol reduction using isoflavones |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070178435 Using nutrient broth comprising nanoparticle composed of hydrophobic core and lipophilic exterior as tool in preservation of mammalian heart ex vivo |
| 08/02/2007 | US20070178221 Methods of making medical devices |